Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PCRX | US
0.20
1.30%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
30/08/2024
15.56
15.37
15.80
15.29
Pacira BioSciences Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL a bupivacaine liposome injectable suspension; ZILRETTA a triamcinolone acetonide extended-release injectable suspension; and iovera system a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals Inc. and changed its name to Pacira BioSciences Inc. in April 2019. Pacira BioSciences Inc. was incorporated in 2006 and is headquartered in Tampa Florida.
View LessValue Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
44.6%1 month
171.8%3 months
113.2%6 months
84.8%10.34
3.57
0.73
0.74
0.39
4.75
1.28
-3.83
175.34M
717.73M
717.73M
-
17.40
-24.50
5.00
7.54
3.16
16.28
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
3.03
Range1M
12.84
Range3M
20.48
Rel. volume
0.45
Price X volume
10.93M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 5.21 | 575.57M | 0.58% | n/a | 117.00% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 15.14 | 421.49M | 0.13% | n/a | 0.00% |
Aquestive Therapeutics Inc | AQST | Drug Manufacturers-Specialty & Generic | 4.53 | 412.50M | 2.95% | n/a | -329.45% |
Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 2.88 | 381.82M | -0.69% | n/a | 42.12% |
Cipher Pharmaceuticals Inc | CPHRF | Drug Manufacturers-Specialty & Generic | 14.05 | 359.52M | 0.79% | 14.64 | 0.00% |
Solid Biosciences Inc | SLDB | Drug Manufacturers-Specialty & Generic | 8.93 | 344.66M | -1.11% | n/a | 13.09% |
Aurora Cannabis Inc | ACB | Drug Manufacturers-Specialty & Generic | 6.08 | 332.34M | 1.16% | n/a | 0.00% |
Elite Pharmaceuticals Inc | ELTP | Drug Manufacturers-Specialty & Generic | 0.2779 | 296.87M | -2.66% | 15.50 | 0.00% |
Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 1.93 | 292.72M | 0.00% | n/a | -471.04% |
Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 4.94 | 263.32M | 5.11% | n/a | 39.24% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Malibu Boats Inc | MBUU | Recreational Vehicles | 36.37 | 743.39M | 4.66% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.25 | 722.36M | 0.32% | 51.36 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 23.91 | 621.28M | 1.18% | 14.36 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.48 | 524.97M | 0.55% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 12.45 | 391.86M | -0.16% | 45.64 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 24.03 | 385.84M | 0.33% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.4 | 326.35M | 0.00% | 12.38 | 0.00% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 28.64 | 316.93M | -0.52% | 16.58 | -621.78% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 18.53 | 314.66M | -0.70% | 34.45 | 26.82% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 15.53 | 251.70M | 1.70% | 9.28 | 15.44% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 4.75 | - | Cheaper |
Ent. to Revenue | 1.28 | - | Cheaper |
PE Ratio | 10.34 | 28.13 | Cheaper |
Price to Book | 0.73 | 11.07 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 113.16 | - | Riskier |
Debt to Equity | 0.74 | -0.91 | Expensive |
Debt to Assets | 0.39 | 0.45 | Par |
Market Cap | 717.73M | - | Emerging |